A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p

Eur J Haematol. 2013 Apr;90(4):349-50. doi: 10.1111/ejh.12065. Epub 2013 Feb 14.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Chromosome Deletion
  • Chromosomes, Human, Pair 17 / genetics
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Maintenance Chemotherapy
  • Male
  • Recurrence
  • Remission Induction
  • Rituximab
  • Smith-Magenis Syndrome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • ofatumumab

Supplementary concepts

  • Chromosome 17 deletion